<div id="readability-page-1">A medical device company based in Irvine, California, Diality Inc., has appointed Peter Donato as its new chief financial officer. Diality is known for developing the Moda-flx™ Hemodialysis System and is currently enrolling patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial for the system. The company is gearing up for a limited market release slated for 2027. Donato brings with him a wealth of experience, boasting nearly 35 years in financial leadership roles.</div>

IBBQ

516820

560600

<p>A medical device company based in Irvine, California, Diality Inc., has appointed Peter Donato as its new chief financial officer. Diality is known for developing the Moda-flx™ Hemodialysis System and is currently enrolling patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial for the system. The company is gearing up for a limited market release slated for 2027. Donato brings with him a wealth of experience, boasting nearly 35 years in financial leadership roles.</p>

Unusual Whales

Invesco Nasdaq Biotechnology ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

ICBCCS SSE STAR Biology and Medicine ETF

China Merchants CSI Biotechnology Theme ETF

iShares Biotechnology ETF

Penghua SSE STAR Biology and Medicine ETF

Proshares UltraShort Nasdaq Biotech

China Southern Hang Seng Biotech ETF(QDII)

Tianhong CNI BIOMEDICINE ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Huaan Hang Seng Biotech ETF

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

E Fund CSI Biotechnology Theme ETF

Guotai CSI Bio-medicine ETF

VanEck Biotech ETF

Minsheng Royal CSI Biotechnology Theme ETF

First Trust NYSE Arca Biotech Index Fd

ChinaAMC CSI Biotechnology Theme ETF

Diality Inc. names Peter Donato as CFO with 35 years of experience, as they prepare for market release in 2027.